The Mount Sinai Bone Program, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J Mol Endocrinol. 2019 Oct;63(3):R73-R80. doi: 10.1530/JME-19-0152.
FSH has a primary function in procreation, wherein it induces estrogen production in females and regulates spermatogenesis in males. However, in line with our discoveries over the past decade of non-unitary functions of pituitary hormones, we and others have described hitherto uncharacterized functions of FSH. Through high-affinity receptors, some of which are variants of the ovarian FSH receptor (FSHR), FSH regulates bone mass, adipose tissue function, energy metabolism, and cholesterol production in both sexes. These newly described actions of FSH may indeed be relevant to the pathogenesis of bone loss, dysregulated energy homeostasis, and disordered lipid metabolism that accompany the menopause in females and aging in both genders. We are therefore excited about the possibility of modulating circulating FSH levels toward a therapeutic benefit for a host of age-associated diseases, including osteoporosis, obesity and dyslipidemia, among other future possibilities.
FSH 在生殖方面具有主要功能,它在女性中诱导雌激素产生,并调节男性的精子发生。然而,根据我们在过去十年中对垂体激素非单一功能的发现,我们和其他人已经描述了 FSH 的迄今尚未确定的功能。通过高亲和力受体,其中一些是卵巢 FSH 受体(FSHR)的变体,FSH 调节两性的骨量、脂肪组织功能、能量代谢和胆固醇生成。FSH 的这些新描述的作用确实可能与女性更年期和两性衰老伴随的骨丢失、能量平衡失调和脂质代谢紊乱的发病机制有关。因此,我们对调节循环 FSH 水平以治疗与年龄相关的多种疾病(包括骨质疏松症、肥胖症和血脂异常症等)的可能性感到兴奋。